In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1018297-63-6, name is (3-(4-Fluorophenyl)-5-methylisoxazol-4-yl)methanol, introducing its new discovery. Quality Control of (3-(4-Fluorophenyl)-5-methylisoxazol-4-yl)methanol
The present invention is concerned with isoxazole-pyridine derivatives of formula I wherein X, R1 to R6 are as described herein. The compounds are active on the GABA A alpha5 receptor binding site and useful for the treatment of cognitive disorders, such as Alzheimer’s disease
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1018297-63-6, and how the biochemistry of the body works.name: (3-(4-Fluorophenyl)-5-methylisoxazol-4-yl)methanol
Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem